Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,343 | 2,727 | 785 | 1,073 | 1,247 |
| Gross Profit | 1,343 | 2,727 | 785 | 1,073 | 1,247 |
| Operating Expenses | 9,349 | 9,131 | 6,963 | 6,868 | 5,627 |
| Operating Income | -8,006 | -6,405 | -6,178 | -5,796 | -4,381 |
| Other Income | 12 | 8 | -18 | -88 | 220 |
| Pre-tax Income | -7,994 | -6,397 | -6,196 | -5,883 | -4,161 |
| Net Income Continuous | -7,994 | -6,559 | -6,196 | -5,883 | -4,161 |
| Net Income | $-7,994 | $-6,559 | $-6,196 | $-5,883 | $-4,161 |
| EPS Basic Total Ops | -15.20 | -13.60 | -11.20 | -11.20 | -8.00 |
| EPS Basic Continuous Ops | -14.85 | -12.34 | -11.51 | -11.52 | -8.36 |
| EPS Diluted Total Ops | -15.20 | -13.60 | -11.20 | -11.20 | -8.00 |
| EPS Diluted Continuous Ops | -14.85 | -12.34 | -11.51 | -11.52 | -8.36 |
| EBITDA(a) | $-7,906 | $-6,219 | $-6,085 | $-5,807 | $-4,286 |